Abedin SM, Guru Murthy GS, Hamadani M, Michaelis LC, et al. Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia. Leukemia 2025 Feb 15. doi: 10.1038/s41375-025-02528.
PMID: 39955432